Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone?
Crossref DOI link: https://doi.org/10.1007/s00408-016-9963-3
Published Online: 2016-11-17
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hosein, Karishma
Le, Jamie
Mura, Marco https://orcid.org/0000-0002-2159-7083
Funding for this research was provided by:
European Respiratory Society (2013 IPF Research Award)
License valid from 2016-11-17